Skip to main content
OpenTrials
Completed

NCT Number: NCT04012008

Standard Versus Comprehensive Care for Post Acute Kidney Injury

The investigators aim to compare between standard versus comprehensive care for post-acute kidney injury who are admitted with acute kidney injury at least stage 2 or receive renal replacement therapy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chulalongkorn University

Bangkok, Thailand

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Acute kidney injury at least stage 2 OR
  • Received renal replacement therapy

Exclusion criteria

  • Post kidney transplantation
  • End-stage renal disease

Treatment and study plan

Comprehensive care

Other
  • Regular follow-up by nephrologists every 1-3 month
  • Multidisciplinary team consisting pharmacists, nurses, and dieticians

Standard care

Other
  • Regular follow-up by internists every 3 month
  • May consult nephrologists case-by-case

Primary outcomes

  1. 1 year major adverse kidney events

    Time frame: 1-year

Sponsors and collaborators

Lead sponsor

Chulalongkorn University

Other

Registry information

Official study title

Standard Versus Comprehensive Care for Post Acute Kidney Injury: A Randomized Controlled Trial

Important dates

Study start
2019
Primary completion
2022
Study completion
2022
First posted
Jul 9, 2019
Registry last updated
Oct 31, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.